home / stock / tlt:cc / tlt:cc quote
Last: | $0.295 |
---|---|
Change Percent: | -1.67% |
Open: | $0.3 |
Close: | $0.295 |
High: | $0.305 |
Low: | $0.29 |
Volume: | 142,475 |
Last Trade Date Time: | 05/06/2022 04:56:38 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.295 | $0.3 | $0.295 | $0.305 | $0.29 | 142,475 | 05-06-2022 |
$0.3 | $0.29 | $0.3 | $0.31 | $0.29 | 143,032 | 05-05-2022 |
$0.31 | $0.28 | $0.31 | $0.315 | $0.28 | 410,483 | 05-04-2022 |
$0.29 | $0.275 | $0.29 | $0.29 | $0.255 | 323,619 | 05-03-2022 |
$0.25 | $0.27 | $0.25 | $0.275 | $0.24 | 728,571 | 05-02-2022 |
$0.27 | $0.29 | $0.27 | $0.29 | $0.27 | 212,604 | 04-29-2022 |
$0.28 | $0.3 | $0.28 | $0.3 | $0.275 | 183,245 | 04-28-2022 |
$0.285 | $0.305 | $0.285 | $0.305 | $0.28 | 147,982 | 04-27-2022 |
$0.305 | $0.315 | $0.305 | $0.315 | $0.3 | 97,517 | 04-26-2022 |
$0.315 | $0.31 | $0.315 | $0.315 | $0.295 | 186,161 | 04-25-2022 |
$0.305 | $0.31 | $0.305 | $0.31 | $0.305 | 35,620 | 04-22-2022 |
$0.305 | $0.31 | $0.305 | $0.315 | $0.305 | 96,900 | 04-21-2022 |
$0.315 | $0.32 | $0.315 | $0.32 | $0.305 | 280,282 | 04-20-2022 |
$0.315 | $0.32 | $0.315 | $0.32 | $0.31 | 114,332 | 04-19-2022 |
$0.31 | $0.32 | $0.31 | $0.325 | $0.3 | 404,712 | 04-18-2022 |
$0.315 | $0.335 | $0.315 | $0.335 | $0.315 | 410,749 | 04-15-2022 |
$0.315 | $0.335 | $0.315 | $0.335 | $0.315 | 410,320 | 04-14-2022 |
$0.325 | $0.345 | $0.325 | $0.345 | $0.315 | 462,929 | 04-13-2022 |
$0.34 | $0.325 | $0.34 | $0.34 | $0.325 | 217,371 | 04-12-2022 |
$0.325 | $0.35 | $0.325 | $0.35 | $0.32 | 299,114 | 04-11-2022 |
News, Short Squeeze, Breakout and More Instantly...
Theralase Technologies Inc. Company Name:
TLT:CC Stock Symbol:
TSXVC Market:
TORONTO, ON / ACCESSWIRE / June 20, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...
TORONTO, ON / ACCESSWIRE / June 19, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...
TORONTO, ON / ACCESSWIRE / June 18, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...